These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

687 related items for PubMed ID: 7043034

  • 1. Estrogens in oral contraceptives: historical perspectives.
    Goldzieher JW.
    Johns Hopkins Med J; 1982 May; 150(5):165-9. PubMed ID: 7043034
    [Abstract] [Full Text] [Related]

  • 2. The formulation of oral contraceptives: does the amount of estrogen make any clinical difference?
    Speroff L.
    Johns Hopkins Med J; 1982 May; 150(5):170-6. PubMed ID: 7043035
    [Abstract] [Full Text] [Related]

  • 3. Current perspectives on combination oral contraceptives.
    Smith MA, Youngkin EQ.
    Clin Pharm; 1984 May; 3(5):485-96. PubMed ID: 6386284
    [Abstract] [Full Text] [Related]

  • 4. Formulation and noncontraceptive uses of the new, low-dose oral contraceptive.
    Batzer FR.
    J Reprod Med; 1984 Jul; 29(7 Suppl):503-12. PubMed ID: 6237195
    [Abstract] [Full Text] [Related]

  • 5. [Oral contraception: failures and risks].
    Foussard-blanpin O, Paillot-renaud P, Bruneau-bigot A.
    Lyon Pharm; 1984 Nov; 35(6):385-93. PubMed ID: 12280590
    [Abstract] [Full Text] [Related]

  • 6. [Cardiovascular risks of oral contraceptives: dose-response relationship].
    Kelleher CC.
    Contracept Fertil Sex (Paris); 1991 Apr; 19(4):285-8. PubMed ID: 12343220
    [Abstract] [Full Text] [Related]

  • 7. [Oral contraception: advantages of estrogen reduction].
    Cohen J.
    Contracept Fertil Sex (Paris); 1993 Jun; 21(6):489-94. PubMed ID: 12318239
    [Abstract] [Full Text] [Related]

  • 8. [Oral contraception: evolution of concepts over the last thirty years].
    Belaisch J, Hommais-loufrani B.
    Contracept Fertil Sex (Paris); 1987 Nov; 15(11 Suppl):1-8. PubMed ID: 12281408
    [Abstract] [Full Text] [Related]

  • 9. [Influence of progestins on adverse effects of oral contraceptives].
    Wynn V.
    Contracept Fertil Sex (Paris); 1985 Jan; 13(1 Suppl):425-30. PubMed ID: 12280210
    [Abstract] [Full Text] [Related]

  • 10. Oral contraceptives.
    Maclennan AH.
    Curr Ther (Seaforth); 1987 Dec; 28(12):113-22. PubMed ID: 12317413
    [Abstract] [Full Text] [Related]

  • 11. [Potential advantages of triphasic combined oral contraceptives in the light of recent epidemiological and endocrinometabolic data].
    Gaspard U, Dubois M.
    Contracept Fertil Sex (Paris); 1982 Sep; 10(9):551-60. PubMed ID: 12311606
    [Abstract] [Full Text] [Related]

  • 12. Prescription contraceptives: countering the risks.
    Ruggiero RJ.
    Am Pharm; 1985 Sep; NS25(9):32-7. PubMed ID: 4050670
    [Abstract] [Full Text] [Related]

  • 13. Oral contraceptives and the risk of cardiovascular disease.
    Med Lett Drugs Ther; 1983 Jul 22; 25(640):69-70. PubMed ID: 6865850
    [Abstract] [Full Text] [Related]

  • 14. [Thirty years after the appearance of the first oral contraceptive, clinical and biological analysis of a new estrogen-progestin combination, a three phase pill containing gestodene].
    Belaisch J, Hommais-loufrani B.
    Fertil Contracept Sex; 1988 Apr 22; 16(4 Suppl):1-8. PubMed ID: 12342078
    [Abstract] [Full Text] [Related]

  • 15. Changes in haemostatic variables induced by oral contraceptives containing 50 micrograms or 30 micrograms oestrogen: absence of dose-dependent effect on PAI-1 activity.
    Scarabin PY, Plu-Bureau G, Zitoun D, Bara L, Guize L, Samama MM.
    Thromb Haemost; 1995 Sep 22; 74(3):928-32. PubMed ID: 8571323
    [Abstract] [Full Text] [Related]

  • 16. Hormonal contraception: current perspectives. Part I. An analysis of available agents.
    Wood GP.
    J Ark Med Soc; 1977 Jun 22; 74(1):63-7. PubMed ID: 141441
    [Abstract] [Full Text] [Related]

  • 17. [Individualization of low-dose oral contraceptives. Pharmacological principles and practical indications for oral contraceptives].
    Cianci A, De Leo V.
    Minerva Ginecol; 2007 Aug 22; 59(4):415-25. PubMed ID: 17923832
    [Abstract] [Full Text] [Related]

  • 18. The history of steroidal contraceptive development: the estrogens.
    Goldzieher JW.
    Perspect Biol Med; 1993 Aug 22; 36(3):363-8. PubMed ID: 8506122
    [Abstract] [Full Text] [Related]

  • 19. [Oral contraception: disadvantages of estrogen reduction].
    Denis C.
    Contracept Fertil Sex (Paris); 1993 Jun 22; 21(6):481-8. PubMed ID: 12318238
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 35.